Clsi Ep28 〈PROVEN〉

Mrs. Park wasn’t abnormal. Aliyah’s reference population was just too young.

“That’s too narrow,” her senior technologist, Marcus, said, frowning at the scatter plot. “Manufacturer says 0.4 to 4.0. If we use ours, we’ll flag half our outpatients as abnormal.”

That night, Aliyah wrote a new lab policy. They would adopt the manufacturer’s broader interval for patients over 65—not out of laziness, but out of a deeper respect for EP28’s core principle: A reference interval is only as good as its reference population. clsi ep28

She pulled the raw data from her 120 healthy subjects. Most were young—residents, techs, nurses under 40. Only seven were over 65. The elderly subgroup, small as it was, had a higher median TSH.

The lower limit of her in-house reference interval was 0.6 mIU/L. The upper limit was 3.2. They would adopt the manufacturer’s broader interval for

Then came the case that changed everything.

Aliyah recruited 120 healthy volunteers from hospital staff: non-pregnant, no chronic meds, no thyroid history. She drew their blood in the gold-top tubes at 8:00 AM sharp, spun them down, and ran them in duplicate. The data came back clean—but wrong. Three weeks later

So when the new automated immunoassay analyzer arrived, she knew the drill. The manufacturer’s reference intervals for thyroid-stimulating hormone (TSH) were neatly printed in the manual: 0.4–4.0 mIU/L. But EP28 was clear: Verify before use. Don’t trust, verify.

Three weeks later, Mrs. Park was in the ER with atrial fibrillation—a known risk of overtreatment in the elderly.